Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Plant biotechnology

Tobacco plants make malaria drug

Inexpensive fast-growing plants have been transformed into factories that churn out an important antimalarial drug.

Artemisinin is the only proven malaria treatment, with hundreds of millions of doses taken every year. The sweet wormwood plant (Artemisia annua) produces a precursor of the compound, artemisinic acid, only in low quantities, and is expensive to grow. To scale-up production, a team led by Ralph Bock at the Max Planck Institute of Molecular Plant Physiology in Potsdam-Golm, Germany, inserted genes for artemisinic acid synthesis into tobacco plants' chloroplasts — abundant organelles that have their own DNA. By adding 'accessory genes' that make artemisinic acid production more efficient, they created a line that pumps out 120 milligrams of artemisinic acid per kilogram of biomass.

The researchers estimate that the world's demand for the drug could be met with just 200 square kilometres of tobacco fields — an area smaller than the city of Boston.

eLife 5, e13664 (2016)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tobacco plants make malaria drug. Nature 534, 592 (2016). https://doi.org/10.1038/534592b

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/534592b

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing